High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0.515. It has been cited 13 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0.119
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
Bristol Myers Squibb
Grant: Support the NCT03391869 study
National Institutes of Health/National Institute of Allergy and Infectious Diseases
Grant: K23 AI117024 (AS)
LUNGevity Foundation
Grant: Career Development Award 2017 (MA)
NIH/NCI
Grant: P30 CA016672 (PI: Peter Pisters)
NIAID NIH HHS
Grant: K23 AI117024
NCI NIH HHS
Grant: P30 CA016672
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 1K23AI117024-01A1
PREDICTORS OF RESPONSE TO BRONCHIAL THERMOPLASTY IN SEVERE ASTHMA
Influential Citations
1
Fields of Study
MeSH Terms
Keywords